Monte Rosa Therapeutics, Inc.

GLUE · Biological Products, (No Diagnostic Substances)
10
Directors
56
Avg Age
5.0
Avg Tenure (yrs)
80%
Independent
Independent Non-independent Near rotation

Board Members

AM
Andrew Schiff, M.D. Chair
WW
Which Term Will Director

...and 8 more directors

The full roster, committee assignments, director pay, and expected-turnover signals for every board on the site are in our free newsletter, Seats Opening.

Get Seats Opening

Source: SEC DEF 14A proxy statement filed 2026-04-29. Data extracted and structured by FindABoardSeat.